STA
CC icon

Summit Trail Advisors’s Chemours CC Stock Holding History

Summit Trail Advisors’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Buy
98,239
+32,083
+48% +$735K 0.03% 609
2026
Q1 		$1.46M Sell
66,156
-26,382
-29% -$459K 0.02% 741
2025
Q4 		$1.09M Buy
92,538
+38,956
+73% +$500K 0.02% 770
2025
Q3 		$849K Buy
53,582
+28,324
+112% +$411K 0.01% 915
2025
Q2 		$289K Buy
+25,258
New +$285K 0.01% 936
2018
Q1 		– Sell
-1,179
Closed -$60K – 630
2017
Q4 		$60K Buy
+1,179
New +$61.8K 0.01% 771

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $4.21B AUM 44.81% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Summit Trail Advisors's CC Position: Q2 2026 in Review

Summit Trail Advisors increased its Chemours (CC) stake by 48% in Q2 2026, buying an estimated $735K and bringing the position to 98,239 shares worth $2.02M. The position accounts for 0.03% of the portfolio, ranked #609.

Summit Trail Advisors first reported a position in CC in Q4 2017 and has held it in 6 quarters since. 473 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Summit Trail Advisors held 98,239 shares of Chemours worth $2.02M as of Q2 2026.
  • Summit Trail Advisors bought 32,083 Chemours shares in Q2 2026, an estimated $735K.
  • Chemours made up 0.03% of Summit Trail Advisors's portfolio in Q2 2026, its #609 holding.
  • Summit Trail Advisors first reported a position in Chemours in Q4 2017 and has held it in 6 quarters since.
  • 473 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.